Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asenapine in Acute Exacerbation of Schizophrenia
NCT01098110Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- May 2010
- Primary completion
- Apr 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of asenapine in schizophrenia, sponsored by Organon & Co.. Started May 2010; status: completed.
02
Drugs
asenapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01098110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01098110.